Top-News
  • Depot
  • Watchlist
  • Glocke

    • Nicox News

    0,351 € -6,40% -0,024 €
    04.12.23 11:25:07 Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A143G8
    ISIN: FR0013018124
    US-Symbol: NICXF
    Typ: Aktie

    Nicox News

    20.10.23 - GlobeNewswire
    Nicox Provides First Half 2023 and Third Quarter 2023 Financial Results and Updates Key Milestones
    Press Release Nicox Provides First Half 2023 and Third Quarter 2023 Financial Results and Updates Key Milestones  Third quarter 2023 U.S. prescriptions for VYZULTA ® ...
    19.07.23 - GlobeNewswire
    Nicox Provides Second Quarter 2023 Financial and Business Highlights
    Press Release Nicox Provides Second Quarter 2023 Financial and Business Highlights Net revenue 1 of € 0.9 million for the second quarter of 2023 Cash position of € 19 .0 million ...
    10.07.23 - GlobeNewswire
    Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million
    Press Release Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million NCX 470 therapeutic profile positively received a m ong U.S. eye care ...
    03.07.23 - GlobeNewswire
    Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset Analysis Showing Superiority over Latanoprost at the World Glaucoma Congress
    Press Release Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset Analysis Showing Superiority over Latanoprost at the World Glaucoma ...
    28.04.23 - GlobeNewswire
    Nicox’s Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China
    Press Release Nicox’s Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China Nicox’s p artner, Ocumension ...
    26.04.23 - GlobeNewswire
    Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023
    Press Release
    26.04.23 - GlobeNewswire
    New Data on Two Nicox’s Assets, NCX 470 and NCX 1728, Presented at ARVO 2023
    Press Release New Data on Two Nicox’s Assets, NCX 470 and NCX 1728, Presented at ARVO 2023 April 26, 2023 – release at 7:30 am CET Sophia Antipolis, France Nicox SA ...
    24.04.23 - GlobeNewswire
    Nicox: 2023 Ordinary Shareholder Meeting to be held on June 1st, 2023
    Press Release Nicox: 2023 Ordinary Shareholder Meeting to be held on June 1 st , 2023 April 24, 2023 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris ...
    19.04.23 - GlobeNewswire
    Nicox Provides First Quarter 2023 Financial and Business Highlights
    Press Release Nicox Provides First Quarter 2023 Financial and Business Highlights Net revenue of € 0.8 million for the first quarter of 202 3 Cash position of € 21.4 million as of ...
    14.04.23 - GlobeNewswire
    Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China
    Press Release Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China Nicox’s p artner, Ocumension ...
    21.03.23 - GlobeNewswire
    Nicox Announces Presentations of Additional NCX 470 Data at the Upcoming World Glaucoma Congress
    Press Release Nicox Announces Presentations of Additional NCX 470 Data at the Upcoming World Glaucoma Congress March 21, 2023 – release at 7:30 am CET Sophia Antipolis, ...
    20.03.23 - GlobeNewswire
    Nicox Reports 2022 Financial Results and Updates Key Future Milestones
    Press Release Nicox Reports 2022 Financial Results and Updates Key Future Milestones Net revenue of € 3.3 million in 2022 Cash position of € 27.7 million as of December 31, ...
    03.03.23 - GlobeNewswire
    Nicox to Present at Upcoming Scientific Conferences
    Press Release Nicox to Present at Upcoming Scientific Conferences March 3, 2023 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, ...
    01.03.23 - GlobeNewswire
    Nicox: Ordinary Shareholder Meeting of February 28, 2023 - Approval of all Resolutions
    Press Release Nicox: Ordinary Shareholder Meeting of February 28, 2023 - Approval of all Resolutions March 1 st , 2023 – release at 7:30 am CET Sophia Antipolis, France Nicox SA ...
    13.02.23 - GlobeNewswire
    Nicox’s Ordinary Shareholder Meeting to be held on February 28, 2023
    Press Release Nicox’s Ordinary Shareholder Meeting to be held on February 28, 2023 February 13, 2023 Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), ...
    24.01.23 - GlobeNewswire
    Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023
    Press Release Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023 January 24, 2023 – release at 7:30 am CET Sophia Antipolis, France ...
    18.01.23 - GlobeNewswire
    Nicox Provides Fourth Quarter 2022 Financial Highlights
    Press Release Nicox Provides Fourth Quarter 2022 Financial Highlights Net revenue € 1 . 0 million for fourth quarter 2022, and € 3 . 3 million for the full year 2022; cash of € 27 . 7 ...
    09.01.23 - GlobeNewswire
    Nicox Announces Proposed Move to Euronext Growth Paris
    Press Release
    22.11.22 - GlobeNewswire
    Nicox Raises €10 Million in Private Placemen
    Press Release
    22.11.22 - GlobeNewswire
    Nicox Raises €10 Million in Private Placement
    Press Release

    Newssuche

    Videos

    30.11.23 0,00%
    Technical Trading: Gold saisonal stärkste Phase voraus
    Gold Long Typ: Turbo Optionsschein WKN: VS6U6T Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »